miR‐221/222 cluster expression improves clinical stratification of non‐muscle invasive bladder cancer (TaT1) patients' risk for short‐term relapse and progression

Publisher： John Wiley & Sons Inc

E-ISSN： 1098-2264|57|3|150-161

ISSN： 1045-2257

Source： GENES, CHROMOSOMES AND CANCER, Vol.57, Iss.3, 2018-03, pp. : 150-161

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical and Pathological Prognostic Factors for Recurrence, Progression and Mortality in Non-Muscle Invasive Bladder Cancer: A Meta-Analysis

By  

Current Urology, Vol. 3, Iss. 3, 2009-10 ,pp. : 113-123

Karger

Access to resources Recommend Favorite

Clinical Significance of Heme Oxygenase-1 Expression in Non-Muscle-Invasive Bladder Cancer

By  

Urologia Internationalis, Vol. 85, Iss. 3, 2010-08 ,pp. : 355-363

Karger

Access to resources Recommend Favorite

Significance of Random Bladder Biopsies in Non-Muscle Invasive Bladder Cancer

By  

Current Urology, Vol. 7, Iss. 2, 2013-10 ,pp. : 57-61

Karger

Access to resources Recommend Favorite

Predictive Factors for Time to Progression after Hyperthermic Mitomycin C Treatment for High-Risk Non-Muscle Invasive Urothelial Carcinoma of the Bladder: An Observational Cohort Study of 97 Patients

By  

Urologia Internationalis, Vol. 96, Iss. 1, 2016-0 ,pp. : 83-90

Karger

Access to resources Recommend Favorite

ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situ

By  

Urologia Internationalis, Vol. 98, Iss. 3, 2016-12 ,pp. : 282-289

Karger

Access to resources Recommend Favorite